BioNxt Solutions Inc. (OTCMKTS:BNXTF) Sees Significant Increase in Short Interest

BioNxt Solutions Inc. (OTCMKTS:BNXTF) saw a large increase in short interest in the month of April. As of April 30th, there was short interest totaling 8,700 shares, an increase of 690.9% from the April 15th total of 1,100 shares. Based on an average daily volume of 7,445 shares, the short-interest ratio is presently 1.2 days. Approximately 0.0% of the company’s shares are sold short.

BioNxt Solutions Trading Down 1.2%

Shares of OTCMKTS BNXTF opened at $0.32 on Wednesday. BioNxt Solutions has a 12 month low of $0.26 and a 12 month high of $0.80. The firm has a market capitalization of $39.03 million, a PE ratio of -7.97 and a beta of 0.69. The firm has a fifty day simple moving average of $0.39 and a two-hundred day simple moving average of $0.44.

BioNxt Solutions (OTCMKTS:BNXTF) last issued its quarterly earnings data on Wednesday, April 29th. The company reported ($0.01) EPS for the quarter.

BioNxt Solutions Company Profile

BioNxt Solutions Inc (OTCMKTS:BNXTF) is a life sciences company specializing in advanced proteomics, metabolomics and bioinformatics solutions. The company’s platform combines state-of-the-art mass spectrometry and chromatography workflows with cloud-based data analysis tools, enabling high-throughput characterization of proteins, metabolites and other biomolecules for research and development purposes.

BioNxt Solutions offers contract research services to clients in the pharmaceutical, biotechnology and academic sectors, providing end-to-end support from sample preparation through to data interpretation.